Brief: AIM Vaccine Sees Unaudited Consolidated FY Net Loss RMB203.0 Mln To RMB270.0 Mln
03/03/2023 10:23
March 3 (Reuters) - AIM Vaccine Co Ltd 6660.HK :
* SEES UNAUDITED CONSOLIDATED NET LOSS RMB203.0 MILLION TO
RMB270.0 MILLION FOR YEAR
* DECREASE IN GROUP'S NET LOSS FOR YEAR DUE TO CONSIDERABLE
DECREASE IN GROUP'S OVERALL EXPENSES FOR YEAR
Further company coverage: 6660.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AIM Vaccine
See all newsBrief: AIM Vaccine Co Submits Application For Human Diploid Cell Rabies Vaccine In China
Brief: AIM Vaccine Says Tibet Bohai To Subscribe 37.4 Million Shares At RMB1.07 Each
Brief: AIM Vaccine Approves Issuance Of Up To 40 Million Domestic Shares
Brief: Aim Vaccine Says Serum-Free Rabies Vaccine Passes Inspection
Brief: AIM Vaccine Updates On 20-Valent Pneumococcal Polysaccharide Conjugate Vaccine